Double-blind trial of mazindol in overweight patients

|October 4, 1975

Abstract:

A 12-week double-blind trial involving 50 patients from a suburban general practice showed a highly significant loss of weight in the group taking 2 mg of mazindol (Sanorex) per day.

Related Experiment Videos

Double-blind trial of mazindol in overweight patients

Related Concept Videos

Cervical smear frequency pattern at an Australian screening centre.

The effect of progestogens on vaginal cytology.

Not Gone but Often Forgotten: Action Needed to Address Tuberculosis in Aboriginal and Torres Strait Islander Communities.

Distribution of Cardiovascular Disease Risk Based on the Updated 2023 Guideline-Recommended Australian Cardiovascular Disease Risk Algorithm and Comparison With the 2012 Algorithm: An Observational Study.

Newborn Screening: Equity for Aboriginal and Torres Strait Islander Families in the Context of Emerging Genomics.

Time for an Update: The Currency of Clinical Guidelines in Australia-A Cross-Sectional Analysis.

Patterns of Osteoporosis Treatment Initiation Following Low-Trauma Fracture: A Population-Based Retrospective Cohort Study in New South Wales, Australia, Using Linked Administrative Health Data.

Forty Years in the Making: Reporting on the Co-Creation of a National Roadmap for Birthing on Country Services for the Best Start to Life.

Development of a series of catechol-containing xanthene fluorophores and their application to detect S-adenosylmethionine (SAM) utilizing catechol-O-methyltransferase (COMT) activities.

Ocular Events Temporally Associated With Minoxidil: A Structured Review.

Angelica sinensis polysaccharide ameliorates chemotherapy-induced intestinal mucositis by regulating gut microbiota-mediated innate immunity and short-chain fatty acid production in Drosophila and mice.

Comparative toxicoproteomics reveals distinct proteostasis and ribosomal stress signatures of CMIT and PHMG.

Political and organizational influences in the side effects of FDA approved drugs.

Carboxymethylated Poria cocos Polysaccharides Mitigate Cisplatin-Induced Hepatorenal Injury by Activating the PLC-PKC-Nrf2 Signaling Pathway.

Related Experiment Videos

Double-blind trial of mazindol in overweight patients

Abstract:

Related Concept Videos

Related Articles